Načítá se...

The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients

SR-aGVHD remains a significant cause of morbidity and mortality in allogeneic HCT recipients. Alemtuzumab has been used with success in adult patients but has not been studied in the pediatric setting. To estimate the effectiveness of alemtuzumab for the treatment of SR-aGVHD in pediatric patients,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Khandelwal, Pooja, Lawrence, Julia, Filipovich, Alexandra H., Davies, Stella M., Bleesing, Jacob J., Jordan, Michael B., Mehta, Parinda, Jodele, Sonata, Grimley, Michael S., Kumar, Ashish, Myers, Kasiani, Marsh, Rebecca A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4167786/
https://ncbi.nlm.nih.gov/pubmed/24384050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/petr.12183
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!